Praxis Precision Medicines, Inc.

PRAX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001689548

SEC filings (opens in a new tab)

No open-market purchases or sales by Praxis Precision Medicines, Inc. insiders were filed in the last 90 days; 309 institutions reported holding it in 13F filings for Q2 2026, worth $11.3B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Praxis Precision Medicines, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of PRAX: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Of which not filed for Q3 2025	Q3 2025	Change
Holders	144	1	152	+9
Shares	24.2M	5.00K	24.7M	+519.5K (+2.2%)
Value	$1.02B	$210.3K	$1.31B	+$291.9M (+28.8%)

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Praxis Precision Medicines, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to PRAX in Q3 2025
Institution	Shares	Value	% of portfolio
Readystate Asset Management LP	109,177	$5.79M	0.28%
Marshall Wace, LLP	68,141	$3.61M	0.00%
Qube Research & Technologies Ltd	57,304	$3.04M	0.00%
Dimensional Fund Advisors LP	37,414	$1.98M	0.00%
SummitTX Capital, L.P.	34,928	$1.85M	0.08%
Y-Intercept (Hong Kong) Ltd	32,186	$1.71M	0.04%
Congress Asset Management Co	30,439	$1.61M	0.01%
First Trust Advisors LP	28,966	$1.54M	0.00%
Knott David M Jr	28,000	$1.48M	0.62%
Dark Forest Capital Management LP	21,684	$1.15M	0.04%
Group One Trading, L.P.	16,628	$881.3K	0.03%
American Century Companies Inc	15,268	$809.2K	0.00%
PCG Wealth Advisors, LLC	14,483	$767.6K	0.22%
SG Americas Securities, LLC	13,496	$715.0K	0.00%
HSBC Holdings PLC	11,172	$594.7K	0.00%
Trexquant Investment LP	8,905	$472.0K	0.00%
Freestone Grove Partners LP	8,269	$438.3K	0.00%
Phoenix Holdings Ltd.	6,817	$361.5K	0.00%
Lion Point Capital, LP	5,700	$302.1K	1.72%
Arizona State Retirement System	5,417	$287.1K	0.00%
Teacher Retirement System of Texas	4,469	$236.9K	0.00%
Virginia Retirement Systems Et Al	3,900	$206.7K	0.00%
Coastal Bridge Advisors, LLC	3,846	$203.8K	0.02%
ProShare Advisors LLC	3,826	$202.8K	0.00%
Clear Street Markets LLC	164	$8.69K	0.00%
Optiver Holding B.V.	140	$7.42K	0.00%
Rockefeller Capital Management L.P.	2	$106	0.00%

Sold out (18)

Institutions that held Praxis Precision Medicines, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of PRAX in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Balyasny Asset Management LLC	369,254	$15.5M
Standard Life Aberdeen plc	214,056	$9.00M
Verition Fund Management LLC	118,482	$4.98M
Schonfeld Strategic Advisors LLC	100,702	$4.23M
Ally Bridge Group (NY) LLC	80,880	$3.40M
Pictet Asset Management Holding SA	79,143	$3.33M
StemPoint Capital LP	32,255	$1.36M
Capital Fund Management S.A.	24,292	$1.02M
UBS Oconnor LLC	21,892	$920.6K
Brevan Howard Capital Management LP	8,503	$357.6K
Virtu Financial LLC	5,058	$213.0K
Maven Securities LTD	5,000	$210.3K
Voya Investment Management LLC	4,919	$206.8K
Toronto Dominion Bank	3,100	$130.4K
Skopos Labs, Inc.	298	$12.5K
Caitong International Asset Management Co., Ltd	219	$9.21K
Twin Peaks Wealth Advisors, LLC	1	$48
National Bank of Canada	1	$42

Not filed for Q3 2025 yet (1)

Institutions that held Praxis Precision Medicines, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PRAX in Q2 2025 that haven't filed for Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Norges Bank	5,000	$210.3K